{"AllianceGenome": "451", "HGNC": "451", "MIM": "604489", "_id": "23600", "_version": 1, "accession": {"genomic": ["AC139783.3", "CH471118.1", "CP068273.2", "EF636492.1", "EF636493.1", "EF636494.1", "EF636495.1", "EF636496.1", "FJ767773.1", "JC739427.1", "NC_000005.10", "NC_060929.1", "NG_016211.1"], "protein": ["AAD10205.1", "AAF22610.1", "AAH09471.1", "AAP35857.1", "AAQ67234.1", "AAQ94259.1", "AAY16192.1", "ABQ59031.1", "ACL67853.1", "ACL67854.1", "ACL67855.1", "BAD96551.1", "BAF85677.1", "BAG50838.1", "BAG51110.1", "CAB44062.1", "CEF39433.1", "EAX10815.1", "EAX10816.1", "EAX10817.1", "EAX10818.1", "NP_001161067.1", "NP_055139.4", "NP_976316.1", "Q9UHK6.2"], "rna": ["AA969512.1", "AF047020.1", "AF158378.1", "AJ130733.1", "AK000912.1", "AK022765.1", "AK222831.1", "AK225749.1", "AK292988.1", "AL545355.3", "AL571115.3", "AY330488.1", "AY330489.1", "AY935981.1", "BC009471.1", "BG708726.1", "BI550368.1", "BQ941482.1", "BT007193.1", "DA156454.1", "EF560721.1", "FJ498906.1", "FJ498907.1", "FJ498908.1", "NM_001167595.2", "NM_001167596.1", "NM_001167597.1", "NM_001167598.1", "NM_014324.6", "NM_203382.3"], "translation": [{"protein": "BAF85677.1", "rna": "AK292988.1"}, {"protein": "AAP35857.1", "rna": "BT007193.1"}, {"protein": "AAD10205.1", "rna": "AF047020.1"}, {"protein": "NP_001161067.1", "rna": "NM_001167595.2"}, {"protein": "NP_976316.1", "rna": "NM_203382.3"}, {"protein": "AAH09471.1", "rna": "BC009471.1"}, {"protein": "AAQ94259.1", "rna": "AY330489.1"}, {"protein": "AAQ67234.1", "rna": "AY330488.1"}, {"protein": "AAY16192.1", "rna": "AY935981.1"}, {"protein": "AAF22610.1", "rna": "AF158378.1"}, {"protein": "ABQ59031.1", "rna": "EF560721.1"}, {"protein": "CAB44062.1", "rna": "AJ130733.1"}, {"protein": "BAD96551.1", "rna": "AK222831.1"}, {"protein": "NP_055139.4", "rna": "NM_014324.6"}, {"protein": "ACL67855.1", "rna": "FJ498908.1"}, {"protein": "ACL67853.1", "rna": "FJ498906.1"}, {"protein": "BAG51110.1", "rna": "AK022765.1"}, {"protein": "ACL67854.1", "rna": "FJ498907.1"}, {"protein": "BAG50838.1", "rna": "AK000912.1"}]}, "alias": ["AMACRD", "CBAS4", "P504S", "RACE", "RM"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "moderate", "classification_date": "2022-03-31T04:00:00.000Z", "disease_label": "alpha-methylacyl-CoA racemase deficiency", "gcep": "Peroxisomal Disorders Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0013681", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3fb8a3ea-cf06-4788-841f-e787f3780a49-2022-03-31T040000.000Z", "sop": "SOP7"}}, "ec": "5.1.99.4", "ensembl": {"gene": "ENSG00000242110", "protein": ["ENSP00000334424", "ENSP00000371504", "ENSP00000371517", "ENSP00000424351", "ENSP00000427227"], "transcript": ["ENST00000335606", "ENST00000382072", "ENST00000382085", "ENST00000502637", "ENST00000506639", "ENST00000514195"], "translation": [{"protein": "ENSP00000334424", "rna": "ENST00000335606"}, {"protein": "ENSP00000371504", "rna": "ENST00000382072"}, {"protein": "ENSP00000427227", "rna": "ENST00000506639"}, {"protein": "ENSP00000371517", "rna": "ENST00000382085"}, {"protein": "ENSP00000424351", "rna": "ENST00000502637"}], "type_of_gene": "protein_coding"}, "entrezgene": "23600", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 9.37690755607, "exp_mis": 151.069211221, "exp_syn": 64.1644049332, "lof_z": 2.06286108773571, "mis_z": 0.400703811334709, "mu_lof": 6.91749712512e-07, "mu_mis": 1.49062471662e-05, "mu_syn": 6.2315837923e-06, "n_lof": 3.0, "n_mis": 141.0, "n_syn": 59.0, "p_li": 0.125255655188202, "p_null": 0.0236855762858875, "p_rec": 0.85105876852591, "syn_z": 0.399689083838345}, "bp": 1185, "cds_end": 34008124, "cds_start": 33988412, "n_exons": 6, "nonpsych": {"exp_lof": 8.38125094003, "exp_mis": 136.626462933, "exp_syn": 57.9692272452, "lof_z": 1.82549553062922, "mis_z": 0.631153030388491, "mu_lof": 6.91749712512e-07, "mu_mis": 1.49062471662e-05, "mu_syn": 6.2315837923e-06, "n_lof": 3.0, "n_mis": 122.0, "n_syn": 52.0, "p_li": 0.0998059130770025, "p_null": 0.0409637113829704, "p_rec": 0.859230375540027, "syn_z": 0.493608985833727}, "nontcga": {"exp_lof": 8.61644688866, "exp_mis": 138.973376122, "exp_syn": 59.0209510779, "lof_z": 2.22352469327899, "mis_z": 0.210181892184905, "mu_lof": 6.91749712512e-07, "mu_mis": 1.49062471662e-05, "mu_syn": 6.2315837923e-06, "n_lof": 2.0, "n_mis": 134.0, "n_syn": 55.0, "p_li": 0.370803641891664, "p_null": 0.0112746689388248, "p_rec": 0.617921689169511, "syn_z": 0.33139647451894}, "transcript": "ENST00000382085.3"}, "exons": [{"cdsend": 34008019, "cdsstart": 33988307, "chr": "5", "position": [[33986985, 33988361], [33989110, 33989502], [33998640, 33998827], [34004573, 34004734], [34005755, 34005899], [34007772, 34008050]], "strand": -1, "transcript": "NM_001167595", "txend": 34008050, "txstart": 33986985}, {"cdsend": 34008019, "cdsstart": 33989092, "chr": "5", "position": [[33986164, 33989502], [33998640, 33998827], [34004573, 34004734], [34005755, 34005899], [34007772, 34008050]], "strand": -1, "transcript": "NM_014324", "txend": 34008050, "txstart": 33986164}, {"cdsend": 34008019, "cdsstart": 33989483, "chr": "5", "position": [[33986164, 33989502], [33998640, 33998827], [34005755, 34005899], [34007772, 34008050]], "strand": -1, "transcript": "NM_203382", "txend": 34008050, "txstart": 33986164}], "exons_hg19": [{"cdsend": 34008124, "cdsstart": 33988412, "chr": "5", "position": [[33987090, 33988466], [33989215, 33989607], [33998745, 33998932], [34004678, 34004839], [34005860, 34006004], [34007877, 34008155]], "strand": -1, "transcript": "NM_001167595", "txend": 34008155, "txstart": 33987090}, {"cdsend": 34008124, "cdsstart": 33989197, "chr": "5", "position": [[33986269, 33989607], [33998745, 33998932], [34004678, 34004839], [34005860, 34006004], [34007877, 34008155]], "strand": -1, "transcript": "NM_014324", "txend": 34008155, "txstart": 33986269}, {"cdsend": 34008124, "cdsstart": 33989588, "chr": "5", "position": [[33986269, 33989607], [33998745, 33998932], [34005860, 34006004], [34007877, 34008155]], "strand": -1, "transcript": "NM_203382", "txend": 34008155, "txstart": 33986269}], "generif": [{"pubmed": 11926890, "text": "AMACR was shown to be overexpressed in prostate cancer"}, {"pubmed": 12213712, "text": "AMACR expression may be a marker of tumor differentiation"}, {"pubmed": 12438241, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12673556, "text": "expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone"}, {"pubmed": 12810662, "text": "AMACR was overexpressed in prostate cancer. One AMACR probeset from an alternatively spliced exon had 88% identity to a 521-bp sequence spanning 4 exons of fumarate hydratase. The predicted sequence revealed a new GLGELIL peptide shared by both proteins."}, {"pubmed": 14612535, "text": "Data suggest that AMACR is essential for optimal growth of prostate cancer cells in vitro and that this enzyme has the potential to be a complementary target with androgen ablation in PCa treatment."}, {"pubmed": 15323145, "text": "AMACR (P504S) has been proven to be one of the few biomarkers that can help distinguish cancer from benign cells, with high sensitivity and specificity for prostate carcinoma"}, {"pubmed": 15330799, "text": "Results demonstrated the promising features of AMACR as a biomarker for prostate cancer in this large series and the potential to develop automated quantitative diagnostic tests."}, {"pubmed": 15880524, "text": "Novel variant of AMACR identified; real time PCR demonstrates that this splice variant is expressed in tumor, normal prostate tissue, and PC3 cell lines"}, {"pubmed": 15941950, "text": "AMACR protein is expressed in normal breast and its expression seems to increase in invasive carcinomas"}, {"pubmed": 15941951, "text": "AMACR expression is significantly associated with prostate cancer progression and suggests that not all surrogate end points may be optimal to define biomarkers of aggressive prostate cancer"}, {"pubmed": 16424894, "text": "AMACR immunoreactivity may be useful in differentiating papillary renal cell carcinoma from metanephric adenoma."}, {"pubmed": 16491480, "text": "expression of PSGR and PSGR2 relative to AMACR in prostate cancer; AMACR was the most overexpressed, but in some cases expression of AMACR was not significantly elevated while PSGR and/or PSGR2 were substantially elevated"}, {"pubmed": 16506014, "text": "Moderate to strong P504S expression in high-grade prostatic intraepithelial neoplasia of biopsy specimens is indicative of an associated adenocarcinoma."}, {"pubmed": 16681682, "text": "AMACR immunohistochemical staining has shown the ability to improve detection of small focal prostatic carcinoma that could be missed by conventional histological examination."}, {"pubmed": 17067752, "text": "Increase in AMACR expression is associated with prostate cancer"}, {"pubmed": 17222253, "text": "Expression in prostatic cancer shows a correlation with Gleason severity score."}, {"pubmed": 17525630, "text": "AMACR overexpression in colorectal carcinoma is correlated with tumor differentiation."}, {"pubmed": 17680641, "text": "AMACR gene variants were unrelated to prostate cancer overall in this study."}, {"pubmed": 17680641, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17683075, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17683075, "text": "Our results confirm an initial report of association between the AMACR gene and the risk of familial prostate cancer."}, {"pubmed": 17684125, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17684125, "text": "Variants in AMACR associated with advanced distal colorectal adenoma were identified and pointed to potential interactions with iburpofen use."}, {"pubmed": 18032455, "text": "Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder."}, {"pubmed": 18080842, "text": "promoter function of AMACR is independent of androgen receptor-mediated signaling"}, {"pubmed": 18279392, "text": "Review about the role of AMACR in the branched-chain fatty amino acids metabolism and its link with cancer."}, {"pubmed": 18500268, "text": "AMACR expression may be a new diagnostic marker for dysplasia carcinoma sequence in Barrett's low-grade neoplastic lesions."}, {"pubmed": 18537123, "text": "In a relatively genetically homogenous Tasmanian population, there is evidence for a significant association between variants within the AMACR gene and prostate cancer risk."}, {"pubmed": 18537123, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18577240, "text": "Increased AMACR expression and its association with tumor venous invasion suggest that alpha-Methylacyl-CoA racemase may play a role in hepatocellular carcinoma development and progression."}, {"pubmed": 18665038, "text": "Overexpression of alpha-methylacyl-CoA racemase ia a useful parameter for identifying dysplasia in Barrett esophagus."}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18712414, "text": "AMACR expression in colorectal cancer was significantly associated with tumor grade, stage, non-mucinous phenotype, and left-sided tumor localization. AMACR staining results were unrelated to clinical outcome."}, {"pubmed": 18785113, "text": "The high level expression of AMACR in high-grade dysplasia and carcinoma suggests that it may be a useful biomarker in distinguishing high-grade dysplasia and carcinoma from low-grade dysplasia."}, {"pubmed": 18788852, "text": "The immunohistochemical profile of clear cell carcinomas of the urinary tract...is positive for P504S"}, {"pubmed": 18835622, "text": "combined alpha-methylacyl coenzyme A racemase/p53 analysis may represent a helpful tool to confirm dysplasia in inflammatory bowel disease."}, {"pubmed": 19064571, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19068396, "text": "Immunohistochemistry with anti-AMACR/TO63 is useful for detecting prostate cancer in the full range of prostate specimens encountered in needle biopsies."}, {"pubmed": 19148275, "text": "deregulation of Alpha-methylacyl-coenzyme A racemase during colon carcinogenesis involves two nonrandom events, resulting in the mutually exclusive existence of double-deletion at CG3 and CG10 and deletion of CG12-16 in a newly identified CpG island"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19384190, "text": "AMACR immunostaining does not seem to be a useful marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma"}, {"pubmed": 19459159, "text": "P504S/AMACR staining might be of great value in cytodiagnosis of prostate lesions"}, {"pubmed": 19605815, "text": "AMACR showed diffuse or focal positivity in cancer, high-grade prostatic intraepithelial neoplasia, and atypia"}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19638170, "text": "The expression of AMACR is increased in benign sebaceous glands and sebaceous hyperplasia; with decreasing AMACR expression in tumors with less sebaceous differentiation"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20102405, "text": "marker of differential diagnosis of kidney cancer"}, {"pubmed": 20189848, "text": "Our study showed that 34betaE12 is the most appropriate negative marker to combine with AMACR as a positive marker for the diagnosis of prostate adenocarcinoma."}, {"pubmed": 20189848, "text": "study showed that 34betaE12 is the most appropriate negative marker to combine with alpha-methylacyl coenzyme A racemase as a positive marker for the diagnosis of prostate adenocarcinoma[34betaE12]"}, {"pubmed": 20503447, "text": "Results describe alpha-methylacyl CoA racemase (AMACR) expression in relation to various dysplasia phenotypes and clinicopathological parameters of sporadic colorectal adenomas."}, {"pubmed": 20636793, "text": "AMACR shows promise as a marker to indicate indefinite dysplasia in Barrett's oesophagus."}, {"pubmed": 20664974, "text": "Examine P504S expressing circulating prostate cells as a marker for prostate cancer."}, {"pubmed": 20821052, "text": "Case Report: AMACR homozygous mutation responsible for adult onset alpha-methyl-acyl-CoA racemase deficiency."}, {"pubmed": 20875727, "text": "The results suggest that AMACR may play a significant role in susceptibility to schizophrenia in male patients."}, {"pubmed": 20877624, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20945498, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21176184, "text": "A combination of high molecular weight cytokeratin and alpha-methylacyl CoA racemase is of great value in combating the morphologically suspicious cases and significantly increasing the diagnostic accuracy in prostate cancer."}, {"pubmed": 21195844, "text": "Our data suggest that AMACR variants have better power than total AMACR in discriminating between CaP and adjacent normal tissue. These findings may be useful for the development of future diagnostic assays"}, {"pubmed": 21441411, "text": "This report shows the first high-throughput screen for the discovery of novel AMACR inhibitors, characterizes the first nonsubstrate-based inhibitors, and validates that AMACR is a viable chemotherapeutic target in vitro."}, {"pubmed": 21457159, "text": "Overexpression of alpha-methylacyl-CoA racemase is associated with CTNNB1 mutations in hepatocellular carcinomas"}, {"pubmed": 22009118, "text": "in the subgroup of papillary renal cell carcinoma both a higher grade and a presence of distant metastases were associated with a lower percentage of alpha-methylacyl CoA racemase (AMACR)expressing tumors."}, {"pubmed": 22078291, "text": "Alpha-methylacyl-coenzyme A racemase expression is associated with mucin phenotypes of gastric neoplasia, particularly with the expression of CDX2 and MUC5AC."}, {"pubmed": 22248277, "text": "High AMACR is associated with prostate cancer."}, {"pubmed": 22507319, "text": "AMACR can be considered a more accurate marker than PTOV1 in the identification of high-grade prostatic intraepithelial neoplasia (HGPIN) and of prostate cancer."}, {"pubmed": 22542076, "text": "Alpha methylacyl-COA racemase cannot discriminate hepatocellular carcinoma from liver cell dysplasiA, although it can separate both of them from nondysplastic lesions."}, {"pubmed": 22593005, "text": "The sensitivity and specificity of AMACR for the diagnosis of prostate adenocarcinoma and benign glands in Japanese patients are lower than those previously reported in Western countries."}, {"pubmed": 22782380, "text": "Our results indicate that alpha-methylacyl-coenzyme A racemase is a useful marker for distinguishing between grade 1 and grade 2 neuroendocrine tumours, and neuroendocrine carcinoma of the stomach"}, {"pubmed": 23235347, "text": "Overall disease-free survival tended to be worse in AMACR-positive patients, and in adenocarcinoma subgroup, it was significantly shorter"}, {"pubmed": 23376124, "text": "role of AMACR in drug metabolism, cancer and drug design"}, {"pubmed": 23434146, "text": "Of the cases of clear cell renal carcinoma there was immunoreactivity for alpha-methylacyl-CoA racemase and strong diffuse immuno-positivity for cytokeratin."}, {"pubmed": 23797726, "text": "ERG immunohistochemistry could be considered in a second round of immunostaining of select difficult cases of foamy gland carcinoma of the prostate with low AMACR expression."}, {"pubmed": 24004067, "text": "Strong AMACR expression is associated with an increased risk of neoplastic progression in Barrett's esophagus."}, {"pubmed": 24119561, "text": "These findings indicate that AMACR expression is strongly associated with endometrial clear cell carcionma and displays a relatively robust diagnostic test performance."}, {"pubmed": 24383053, "text": "Genetic variations of AMACR are associated with the risk of sporadic prostate cancer that underwent radical prostatectomy in Koreans."}, {"pubmed": 24675392, "text": "AMACR is a useful immunohistochemical marker for the differential diagnosis of solid pseudopapillary neoplasms of the pancreas."}, {"pubmed": 24705308, "text": "AMACR should be the first-line positive marker for confirmation of a diagnosis of minimal adenocarcinoma of the prostate."}, {"pubmed": 24833092, "text": "AMACR overexpression was identified as an important prognosticator and a potential therapeutic target in the future"}, {"pubmed": 25092674, "text": "AMACR might be a potential prognostic marker for predicting early recurrence/metastasis of hepatocellular carcinoma after hepatectomy."}, {"pubmed": 25149154, "text": "Our results suggest AMACR as an immunohistochemical marker for distinguishing malignant melanomas and dysplastic nevi from conventional melanocytic nevi."}, {"pubmed": 25307752, "text": "The overexpression of AMACR in prostate cancer was not associated with dietary influences on phytanic acid."}, {"pubmed": 25313761, "text": "Combination of p63 and AMACR is of great additional value in combating the morphologically suspicious cases and should be used on case to case basis especially in prostatic needle biopsies and small foci lesions."}, {"pubmed": 25384383, "text": "Overexpressed AMACR in myxofibrosarcomas can be amplification-driven, associated with tumor aggressiveness, and may be relevant as a druggable target."}, {"pubmed": 25473890, "text": "AMACR amplification is a mechanism driving increased mRNA and protein expression and conferring aggressiveness through heightened cell proliferation in gastrointestinal stromal tumors"}, {"pubmed": 25551297, "text": "In diagnosis of ovarian clear cell carcinoma, AMACR is highly specific but suboptimally sensitive."}, {"pubmed": 25773837, "text": "The D175G and M9V polymorphisms of the AMACR gene are related to prostate cancer. The S201L polymorphism might be linked with prostate cancer risk. no association was observed between K277E or Q239H polymorphisms and susceptibility to prostate cancer."}, {"pubmed": 26648339, "text": "AMACRwas not regulated in the white blood cells of multiple sclerosis patients"}, {"pubmed": 26766126, "text": "IMP3 has a similar specificity, but a better sensitivity, intensity, and extent of reactivity in comparison with AMACR, and may be used as an alternative to AMACR, in support of the diagnosis of BE-dysplasia and EAC"}, {"pubmed": 26888362, "text": "AMACR is expressed in most of the chordomas but only in a minority of chondrosarcomas. AMACR may serve as IHC marker of chordoma with differentiating ability comparable to that of beta-catenin."}, {"pubmed": 26928323, "text": "AMACR transcripts were detected in all radical prostatectomy(RP)-prostate cancer and RP-Benign samples but not in non-cancerous cystoprostatectomy samples, which suggest a global increase of AMACR expression in cancerous prostates."}, {"pubmed": 27271990, "text": "Data show a significant association between Alpha-methylacyl-CoA racemase (AMACR) and ERG protein with prognostic implication in prostate cancer."}, {"pubmed": 28384107, "text": "AMACR staining was positively expressed in 86 of the prostate carcinoma cases and completely absent in remaining 12."}, {"pubmed": 28508828, "text": "As an adjunct to biopsy, AMACR and HMWCK have value for resolving diagnostically challenging cases"}, {"pubmed": 28741117, "text": "High AMACR expression is associated with prostate cancer."}, {"pubmed": 28902459, "text": "Single nucleotide polymorphism in AMACR gene is associated with schizophrenia risk loci with potential implications for neurocognitive performance."}, {"pubmed": 29179959, "text": "AMACR expression was studied in normal mucosa of the colon, adenomas with different degrees of dysplasia, colonic carcinomas, lymph nodes and liver metastases of colonic carcinomas. Expression was nearly absent in samples of normal mucosa, increased in both adenomas and carcinomas, decreased in lymph node metastases but was significantly increased in liver metastases."}, {"pubmed": 29277318, "text": "Results show that AMACR expression is significantly high in patients with prostate cancer."}, {"pubmed": 29725255, "text": "High expression of AMACR was not only a key adverse prognostic factor but also a potential therapeutic target in oral squamous cell carcinoma"}, {"pubmed": 30317298, "text": "As the mutation was found in the healthy samples as well, it can be said that the current mutation AMACR can be involved in some other forms of peripheral neuropathy which can be with other phenotypes."}, {"pubmed": 30337219, "text": "High AMACR expression is associated with prostate cancer."}, {"pubmed": 31361605, "text": "Napsin-A and AMACR are Superior to HNF-1beta in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract."}, {"pubmed": 32031122, "text": "Expression of alpha-methylacyl-CoA racemase in vaginal gastric-type adenocarcinoma and uterine clear cell carcinoma."}, {"pubmed": 33433414, "text": "Correlation of cyclin D1, HER2, and AMACR expressions with histologic grade in bladder urothelial carcinomas."}, {"pubmed": 34505419, "text": "Oncogenic Activity of Solute Carrier Family 45 Member 2 and Alpha-Methylacyl-Coenzyme A Racemase Gene Fusion Is Mediated by Mitogen-Activated Protein Kinase."}, {"pubmed": 35696768, "text": "P504S/alpha-methylacyl-CoA racemase, HNF1beta and napsin A in morular metaplasia and clear cell carcinoma of the endometrium: An immunohistochemical analysis."}, {"pubmed": 35998819, "text": "Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation."}, {"pubmed": 36577560, "text": "AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasive Apocrine Breast Cancers."}, {"pubmed": 38579443, "text": "Alpha-methyl CoA racemase (AMACR) reactivity across the spectrum of clear cell renal cell neoplasms."}], "genomic_pos": {"chr": "5", "end": 34008104, "ensemblgene": "ENSG00000242110", "start": 33986165, "strand": -1}, "genomic_pos_hg19": {"chr": "5", "end": 34008220, "start": 33986283, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0006699", "qualifier": "involved_in", "term": "bile acid biosynthetic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006699", "qualifier": "involved_in", "term": "bile acid biosynthetic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0008206", "qualifier": "involved_in", "term": "bile acid metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008206", "pubmed": 10655068, "qualifier": "involved_in", "term": "bile acid metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0033540", "qualifier": "involved_in", "term": "fatty acid beta-oxidation using acyl-CoA oxidase"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 15941950, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005739", "qualifier": "is_active_in", "term": "mitochondrion"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005739", "pubmed": [7649182, 11060359, 20102405], "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005777", "pubmed": [7649182, 11060359], "qualifier": "located_in", "term": "peroxisome"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005782", "qualifier": "located_in", "term": "peroxisomal matrix"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043231", "qualifier": "located_in", "term": "intracellular membrane-bounded organelle"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0008111", "qualifier": "enables", "term": "alpha-methylacyl-CoA racemase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008111", "pubmed": [7649182, 11060359], "qualifier": "enables", "term": "alpha-methylacyl-CoA racemase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0008111", "pubmed": 10655068, "qualifier": "enables", "term": "alpha-methylacyl-CoA racemase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008111", "qualifier": "enables", "term": "alpha-methylacyl-CoA racemase activity"}]}, "homologene": {"genes": [[5141, 3877008], [6239, 174559], [6239, 181140], [7165, 1277563], [7227, 35337], [7955, 553653], [8364, 493271], [9031, 427429], [9544, 698365], [9598, 461953], [9606, 23600], [9615, 612603], [9913, 540376], [10090, 17117], [10116, 25284], [318829, 2680524]], "id": 7410}, "interpro": [{"desc": "CoA-transferase family III", "id": "IPR003673", "short_desc": "CoA-Trfase_fam_III"}, {"desc": "CoA-transferase family III domain 1 superfamily", "id": "IPR023606", "short_desc": "CoA-Trfase_III_dom_1_sf"}, {"desc": "CoA-transferase family III domain 3 superfamily", "id": "IPR044855", "short_desc": "CoA-Trfase_III_dom3_sf"}], "ipi": ["IPI00005918", "IPI00914928", "IPI00930327", "IPI00930713", "IPI00964368"], "map_location": "5p13.2", "name": "alpha-methylacyl-CoA racemase", "other_names": ["2-methylacyl-CoA racemase", "alpha-methylacyl-CoA racemase"], "pantherdb": {"HGNC": "451", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1098273", "ortholog_type": "LDO", "panther_family": "PTHR48228", "taxid": 10090, "uniprot_kb": "O09174"}, {"RGD": "3048", "ortholog_type": "LDO", "panther_family": "PTHR48228", "taxid": 10116, "uniprot_kb": "P70473"}, {"Ensembl": "ENSGALG00000003326", "ortholog_type": "LDO", "panther_family": "PTHR48228", "taxid": 9031, "uniprot_kb": "F1NKY1"}, {"ZFIN": "ZDB-GENE-050522-484", "ortholog_type": "LDO", "panther_family": "PTHR48228", "taxid": 7955, "uniprot_kb": "A0A2R8QEJ3"}, {"WormBase": "WBGene00014128", "ortholog_type": "O", "panther_family": "PTHR48228", "taxid": 6239, "uniprot_kb": "Q09618"}, {"WormBase": "WBGene00016034", "ortholog_type": "LDO", "panther_family": "PTHR48228", "taxid": 6239, "uniprot_kb": "Q18122"}, {"FlyBase": "FBgn0032881", "ortholog_type": "LDO", "panther_family": "PTHR48228", "taxid": 7227, "uniprot_kb": "Q9VIK0"}, {"EnsemblGenome": "BAB96607", "ortholog_type": "O", "panther_family": "PTHR48228", "taxid": 562, "uniprot_kb": "P31572"}, {"EnsemblGenome": "BAA16247", "ortholog_type": "LDO", "panther_family": "PTHR48228", "taxid": 562, "uniprot_kb": "P69902"}], "uniprot_kb": "Q9UHK6"}, "pathway": {"humancyc": {"id": "PWY-6061", "name": "bile acid biosynthesis, neutral pathway"}, "kegg": [{"id": "hsa00120", "name": "Primary bile acid biosynthesis - Homo sapiens (human)"}, {"id": "hsa04146", "name": "Peroxisome - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-192105", "name": "Synthesis of bile acids and bile salts"}, {"id": "R-HSA-193368", "name": "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}, {"id": "R-HSA-193775", "name": "Synthesis of bile acids and bile salts via 24-hydroxycholesterol"}, {"id": "R-HSA-194068", "name": "Bile acid and bile salt metabolism"}, {"id": "R-HSA-389887", "name": "Beta-oxidation of pristanoyl-CoA"}, {"id": "R-HSA-390918", "name": "Peroxisomal lipid metabolism"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-8957322", "name": "Metabolism of steroids"}, {"id": "R-HSA-8978868", "name": "Fatty acid metabolism"}, {"id": "R-HSA-9033241", "name": "Peroxisomal protein import"}, {"id": "R-HSA-9033241", "name": "Peroxisomal protein import"}, {"id": "R-HSA-9609507", "name": "Protein localization"}, {"id": "R-HSA-9609507", "name": "Protein localization"}], "smpdb": [{"id": "SMP00035", "name": "Bile Acid Biosynthesis"}, {"id": "SMP00314", "name": "Congenital Bile Acid Synthesis Defect Type II"}, {"id": "SMP00315", "name": "Cerebrotendinous Xanthomatosis (CTX)"}, {"id": "SMP00316", "name": "Zellweger Syndrome"}, {"id": "SMP00317", "name": "Familial Hypercholanemia (FHCA)"}, {"id": "SMP00318", "name": "Congenital Bile Acid Synthesis Defect Type III"}, {"id": "SMP00720", "name": "27-Hydroxylase Deficiency"}], "wikipathways": [{"id": "WP4545", "name": "Oxysterols derived from cholesterol"}, {"id": "WP5064", "name": "7-oxo-C and 7beta-HC pathways"}]}, "pfam": "PF02515", "pharmgkb": "PA24757", "pharos": {"target_id": 2951, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF263331", "relationship": "is"}, {"id": "GNF263332", "relationship": "is"}, {"id": "GNF263333", "relationship": "is"}, {"id": "GNF263334", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF163705", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF035544", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF079470", "relationship": "is"}, {"id": "GNF079471", "relationship": "is"}, {"id": "GNF079472", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052860", "relationship": "is"}, {"id": "GNF057625", "relationship": "is"}, {"id": "GNF072737", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF067639", "relationship": "is"}, {"id": "GNF067640", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF000429", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF106109", "relationship": "is"}, {"id": "GNF145755", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000005.10", "NC_060929.1", "NG_016211.1"], "protein": ["NP_001161067.1", "NP_055139.4", "NP_976316.1"], "rna": ["NM_001167595.2", "NM_001167596.1", "NM_001167597.1", "NM_001167598.1", "NM_014324.6", "NM_203382.3"], "translation": [{"protein": "NP_976316.1", "rna": "NM_203382.3"}, {"protein": "NP_001161067.1", "rna": "NM_001167595.2"}, {"protein": "NP_055139.4", "rna": "NM_014324.6"}]}, "reporter": {"HG-U133_Plus_2": ["209424_s_at", "209425_at", "209426_s_at", "217111_at", "217113_at", "236365_at"], "HG-U95Av2": "41706_at", "HTA-2_0": "TC05003422.hg.1", "HuEx-1_0": "2852742", "HuGene-1_1": "8111430", "HuGene-2_1": "16995097"}, "summary": "This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011].", "symbol": "AMACR", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412374"}, "unigene": "Hs.508343", "uniprot": {"Swiss-Prot": "Q9UHK6", "TrEMBL": "D6RB81"}, "wikipedia": {"url_stub": "Alpha-methylacyl-CoA racemase"}}